BB
BB Biotech Portfolio holdings
AUM
$3.98B
1-Year Return
15.06%
This Quarter Return
+31.67%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$3.09B
AUM Growth
+$628M
(+26%)
Cap. Flow
+$55.2M
Cap. Flow
% of AUM
1.79%
Top 10 Holdings %
Top 10 Hldgs %
71.33%
Holding
29
New
3
Increased
10
Reduced
10
Closed
1
Top Buys
| 1 |
PTC Therapeutics
PTCT
|
$63.6M |
| 2 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$51.7M |
| 3 |
CEMP
Cempra, Inc.
CEMP
|
$18.2M |
| 4 |
Gilead Sciences
GILD
|
$14.1M |
| 5 |
Puma Biotechnology
PBYI
|
$8.52M |
Top Sells
| 1 |
Ionis Pharmaceuticals
IONS
|
$40.7M |
| 2 |
CELG
Celgene Corp
CELG
|
$19.6M |
| 3 |
Incyte
INCY
|
$18.3M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$14.4M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$10.2M |
Sector Composition
| 1 | Healthcare | 81.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Innoviva
INVA
$1.32B
| $14.8M | 0.48% |
1,043,244
+300,000
| +40% | +$4.25M |
|
|
ACHN
27
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $13.2M | 0.43% |
1,079,340
-200,000
| -16% | -$2.45M |
|
|
ECYT
28
DELISTED
Endocyte, Inc. Common Stock
ECYT
| – | – |
-683,522
| Closed | -$4.16M |
|